Transmyocardial laser revascularization (TMLR) in patients with unstable angina and low ejection fraction. 1998

G Lutter, and B Saurbier, and E Nitzsche, and F Kletzin, and J Martin, and C Schlensak, and C Lutz, and F Beyersdorf
Department of Cardiovascular Surgery, Albert-Ludwigs-University, Freiburg, Germany. LUTTER@CH11.UKL.UNI-FREIBURG.DE

OBJECTIVE Does perioperative use of the intraaortic balloon pump (IABP) improve the postsurgical outcome of patients presenting with endstage coronary artery disease, unstable angina and low ejection fraction transferred for transmyocardial laser revascularization (TMLR)? METHODS TMLR, as sole therapy combined with the perioperative use of an intraaortic balloon pump has been assessed in seven patients with endstage coronary artery disease, unstable angina and low ejection fraction (EF < 35%). Six out of seven patients had signs of congestive heart failure. These patients are compared with 23 patients with endstage coronary artery disease, stable angina and EF > 35%, who were treated with TMLR as sole therapy without the use of IABP. The creation of transmural channels was performed by a CO2-laser. All patients were evaluated by hybrid positron emission tomography (perfusion SPECT and viability PET) and ventriculography preoperatively. Echocardiography, clinical status and hemodynamic assessment by Swan Ganz catheter were performed perioperatively. RESULTS The perioperative mortality of this combined procedure (TMLR and IABP) was zero. Three out of seven patients had pneumonia with complete recovery. Swan Ganz catheter examinations showed deterioration of LV-function after TMLR intraoperatively and improvement after 2 h and further after 6 h on ICU (P < 0.05). In contrast, a decrease of LV-function in sole TMLR patients with an EF > 35%) has not been observed. Patients with EF < 35% needed the IABP for 2.3 days and moderate dose catecholamines for a mean of 3.0 days. The postoperative EF and resting wall motion score index (WMSI) of all analysed LV segments (evaluated by echocardiography) did not change compared to baseline (EF 31.3+/-2.6 preop. to 32.8+/-3.2 postop.; WMSI: 1.75+/-0.14 at baseline to 1.71+/-0.17 postop.). The average Canadian Angina Class at the time of discharge decreased from 4.0+/-0 (baseline) to 2.3+/-0.5 (P < 0.05) and the NYHA-Index from 3.9+/-0.3 to 2.7+/-0.5. No patient had signs of angina pectoris, whereas two patients still had signs of congestive heart failure. CONCLUSIONS The reported data support our concept to start IABP preoperatively in patients with reduced LV contractile reserve in order to provide cardiac support during the postoperative phase of reversible decline of LV-function induced by TMLR.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009204 Myocardial Revascularization The restoration of blood supply to the myocardium. (From Dorland, 28th ed) Internal Mammary Artery Implantation,Myocardial Revascularizations,Revascularization, Myocardial,Revascularizations, Myocardial
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011300 Preoperative Care Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed) Care, Preoperative,Preoperative Procedure,Preoperative Procedures,Procedure, Preoperative,Procedures, Preoperative
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

G Lutter, and B Saurbier, and E Nitzsche, and F Kletzin, and J Martin, and C Schlensak, and C Lutz, and F Beyersdorf
April 2003, Nihon rinsho. Japanese journal of clinical medicine,
G Lutter, and B Saurbier, and E Nitzsche, and F Kletzin, and J Martin, and C Schlensak, and C Lutz, and F Beyersdorf
January 1998, Nursing spectrum (D.C./Baltimore metro ed.),
G Lutter, and B Saurbier, and E Nitzsche, and F Kletzin, and J Martin, and C Schlensak, and C Lutz, and F Beyersdorf
August 1997, Herz,
G Lutter, and B Saurbier, and E Nitzsche, and F Kletzin, and J Martin, and C Schlensak, and C Lutz, and F Beyersdorf
November 1998, Circulation,
G Lutter, and B Saurbier, and E Nitzsche, and F Kletzin, and J Martin, and C Schlensak, and C Lutz, and F Beyersdorf
October 1999, The Annals of thoracic surgery,
G Lutter, and B Saurbier, and E Nitzsche, and F Kletzin, and J Martin, and C Schlensak, and C Lutz, and F Beyersdorf
August 1998, Journal of clinical laser medicine & surgery,
G Lutter, and B Saurbier, and E Nitzsche, and F Kletzin, and J Martin, and C Schlensak, and C Lutz, and F Beyersdorf
October 1999, Annals of nuclear medicine,
G Lutter, and B Saurbier, and E Nitzsche, and F Kletzin, and J Martin, and C Schlensak, and C Lutz, and F Beyersdorf
August 1999, The Kobe journal of medical sciences,
G Lutter, and B Saurbier, and E Nitzsche, and F Kletzin, and J Martin, and C Schlensak, and C Lutz, and F Beyersdorf
January 2007, Zhonghua xin xue guan bing za zhi,
G Lutter, and B Saurbier, and E Nitzsche, and F Kletzin, and J Martin, and C Schlensak, and C Lutz, and F Beyersdorf
December 2005, The Annals of thoracic surgery,
Copied contents to your clipboard!